TNSN08383A1 - Renin inhibitors for the treatment of hypertension - Google Patents

Renin inhibitors for the treatment of hypertension

Info

Publication number
TNSN08383A1
TNSN08383A1 TNP2008000383A TNSN08383A TNSN08383A1 TN SN08383 A1 TNSN08383 A1 TN SN08383A1 TN P2008000383 A TNP2008000383 A TN P2008000383A TN SN08383 A TNSN08383 A TN SN08383A TN SN08383 A1 TNSN08383 A1 TN SN08383A1
Authority
TN
Tunisia
Prior art keywords
hypertension
treatment
renin inhibitors
methods
cessation
Prior art date
Application number
TNP2008000383A
Other languages
English (en)
Inventor
Andrew Satlin
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38420678&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TNSN08383(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TNSN08383A1 publication Critical patent/TNSN08383A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TNP2008000383A 2006-04-03 2008-09-26 Renin inhibitors for the treatment of hypertension TNSN08383A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78884206P 2006-04-03 2006-04-03
PCT/US2007/065564 WO2007118023A1 (en) 2006-04-03 2007-03-30 Renin inhibitors for the treatment of hypertension

Publications (1)

Publication Number Publication Date
TNSN08383A1 true TNSN08383A1 (en) 2009-12-29

Family

ID=38420678

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2008000383A TNSN08383A1 (en) 2006-04-03 2008-09-26 Renin inhibitors for the treatment of hypertension

Country Status (20)

Country Link
US (1) US20090062395A1 (https=)
EP (1) EP2004167A1 (https=)
JP (1) JP2009532494A (https=)
KR (1) KR20080108515A (https=)
CN (1) CN101415413A (https=)
AU (1) AU2007234917B2 (https=)
BR (1) BRPI0710095A2 (https=)
CA (1) CA2645260A1 (https=)
CL (1) CL2007000912A1 (https=)
IL (1) IL193905A0 (https=)
MA (1) MA30387B1 (https=)
MX (1) MX2008012729A (https=)
NO (1) NO20084625L (https=)
NZ (1) NZ571251A (https=)
RU (1) RU2008143055A (https=)
SG (1) SG170830A1 (https=)
TN (1) TNSN08383A1 (https=)
TW (1) TW200806283A (https=)
WO (1) WO2007118023A1 (https=)
ZA (1) ZA200807615B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009087116A1 (en) * 2008-01-11 2009-07-16 Novartis Ag Use of spp100 for the treatment of acute mi
CN102212012A (zh) * 2010-04-12 2011-10-12 上海源力生物技术有限公司 一种合成阿利克伦的中间体及其制备方法
WO2013057313A1 (en) 2011-10-20 2013-04-25 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the detection and the treatment of cardiac remodeling
CA3137138A1 (en) * 2019-04-18 2020-10-22 EyePoint Pharmaceuticals, Inc. Methods of treating hypertension with activators of tie-2

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5659065A (en) * 1994-04-18 1997-08-19 Novartis Corporation Alpha-aminoalkanoic acids and reduction products
MY119161A (en) * 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
US5606078A (en) * 1994-04-18 1997-02-25 Ciba-Geigy Corporation 3,5-Disubstituted tetrahydrofuran-2-ones
CA2490811A1 (en) * 2002-06-28 2004-01-08 Novartis Ag Use of organic compounds
WO2004100871A2 (en) * 2003-05-09 2004-11-25 Pharmacia Corporation Combination of an aldosterone receptor antagonist and a renin inhibitor
US20050209141A1 (en) * 2003-10-17 2005-09-22 Silver Randi B Mast cell-derived renin
PE20142101A1 (es) * 2004-03-17 2014-12-27 Novartis Ag Composiciones farmaceuticas de aliskiren
CA2581927C (en) * 2004-09-27 2013-04-09 Pantarhei Bioscience B.V. Treatment or prevention of unscheduled bleeding in women on progestogen containing medication

Also Published As

Publication number Publication date
BRPI0710095A2 (pt) 2011-08-02
JP2009532494A (ja) 2009-09-10
CN101415413A (zh) 2009-04-22
TW200806283A (en) 2008-02-01
AU2007234917A1 (en) 2007-10-18
MX2008012729A (es) 2008-10-14
AU2007234917B2 (en) 2011-05-12
MA30387B1 (fr) 2009-05-04
NO20084625L (no) 2008-11-03
IL193905A0 (en) 2009-08-03
CA2645260A1 (en) 2007-10-18
CL2007000912A1 (es) 2008-03-14
NZ571251A (en) 2011-12-22
SG170830A1 (en) 2011-05-30
KR20080108515A (ko) 2008-12-15
US20090062395A1 (en) 2009-03-05
ZA200807615B (en) 2009-10-28
WO2007118023A1 (en) 2007-10-18
EP2004167A1 (en) 2008-12-24
RU2008143055A (ru) 2010-05-10

Similar Documents

Publication Publication Date Title
ZA202208783B (en) Kras mutant protein inhibitors
MX2009004984A (es) Metodos para conservar la funcion renal utilizando inhibidores de oxidoreductasa de xantina.
DE60329001D1 (en) 8-hydroxychinolinderivate
WO2008024439A3 (en) 4-aminoquinazoline derivatives and methods of use thereof
IL193252A0 (en) N-hydroxyacrylamide compounds
WO2008033798A3 (en) A pyrrolopyrazin as syk-kinase inhibitor
WO2010108074A3 (en) Inhibitors of pi3 kinase
WO2008077057A3 (en) Cytoskeletal active rho kinase inhibitor compounds, composition and use
MY153243A (en) Compound for inhibiting mitotic progression
MY147832A (en) Compounds for enzyme inhibition
MX346186B (es) Inhibidores de proteina cinasas.
WO2007101232A3 (en) Inhibition of jak2 as a treatment of pulmonary arterial hypertension
TN2012000458A1 (en) Uses of dgat1 inhibitors
GEP20125708B (en) Hydroxamate-based inhibitors of deacetylases b
WO2009086426A3 (en) Soluble epoxide hydrolase inhibitors for the treatment of endothelial dysfunction
WO2008064866A8 (en) Treatment for multiple myeloma
WO2008109991A8 (en) Inhibitors of carnitine palmitoyltransferase and treating cancer
IL178100A0 (en) 5-amino-4-hydroxy-7-(1h-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension
WO2007019153A3 (en) Methods for treating hypertension
TNSN08383A1 (en) Renin inhibitors for the treatment of hypertension
WO2010019701A3 (en) Diaryl urea derivatives
MX2007004020A (es) Uso de inhibidores de renina para la prevencion o tratamiento de disfuncion diastolica o falla cardiaca diastolica.
WO2009148600A8 (en) Deuterated lysine-based compounds
WO2012119006A3 (en) Derivatives of pyrazole-substituted amino-heteroaryl compounds
WO2010005585A3 (en) 4-aminoquinazoline prodrugs